Healthcare provider profile · identity verified

Mark Robert Kurzawa, MD

Family Practice · CLINTON TWP, MI · NPI 1265482095

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	353	91
Atorvastatin Calcium	Atorvastatin Calcium	324	96
Amlodipine Besylate	Amlodipine Besylate	288	83
Rosuvastatin Calcium	Rosuvastatin Calcium	278	77
Losartan Potassium	Losartan Potassium	248	75
Metoprolol Succinate	Metoprolol Succinate	240	66
Fluticasone Propionate	Fluticasone Propionate	205	104
Omeprazole	Omeprazole	181	64
Lisinopril	Lisinopril	176	46
Famotidine	Famotidine	157	68
Pantoprazole Sodium	Pantoprazole Sodium	153	49
Pravastatin Sodium	Pravastatin Sodium	146	36
Metformin Hcl	Metformin Hcl	143	42
Tamsulosin Hcl	Tamsulosin Hcl	123	35
Furosemide	Furosemide	121	35
Prednisone	Prednisone	117	72
Albuterol Sulfate Hfa	Albuterol Sulfate	115	52
Trazodone Hcl	Trazodone Hcl	115	29
Alprazolam	Alprazolam	110	31
Meloxicam	Meloxicam	108	45
Metformin Hcl Er	Metformin Hcl	96	27
Gabapentin	Gabapentin	92	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	18
Methylprednisolone	Methylprednisolone	91	77
Eliquis	Apixaban	85	20
Hydrochlorothiazide	Hydrochlorothiazide	85	25
Simvastatin	Simvastatin	83	27
Cephalexin	Cephalexin	75	58
Doxycycline Hyclate	Doxycycline Hyclate	72	63
Mounjaro	Tirzepatide	72	13
Allopurinol	Allopurinol	71	21
Escitalopram Oxalate	Escitalopram Oxalate	71	18
Methocarbamol	Methocarbamol	68	32
Metoprolol Tartrate	Metoprolol Tartrate	68	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	16
Potassium Chloride	Potassium Chloride	57	20
Lorazepam	Lorazepam	55	11
Ezetimibe	Ezetimibe	54	18
Ibuprofen	Ibuprofen	54	26
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	13
Celecoxib	Celecoxib	45	13
Levofloxacin	Levofloxacin	45	40
Mupirocin	Mupirocin	44	37
Glimepiride	Glimepiride	43	15
Ramipril	Ramipril	43	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	11
Sertraline Hcl	Sertraline Hcl	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	32
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	28
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	14
Carvedilol	Carvedilol	34	12
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Metronidazole	Metronidazole	34	23
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	28
Novolog Flexpen	Insulin Aspart	32	suppressed
Azithromycin	Azithromycin	31	28
Finasteride	Finasteride	31	12
Montelukast Sodium	Montelukast Sodium	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	12
Lovastatin	Lovastatin	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	23
Synthroid	Levothyroxine Sodium	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Spironolactone	Spironolactone	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Tiotropium Bromide	Tiotropium Bromide	20	suppressed
Amoxicillin	Amoxicillin	19	15
Bupropion Xl	Bupropion Hcl	19	suppressed
Atenolol	Atenolol	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Diazepam	Diazepam	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Metolazone	Metolazone	18	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Ozempic	Semaglutide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	11
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Hydrocortisone	Hydrocortisone	16	13
Meclizine Hcl	Meclizine Hcl	16	11
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Testosterone	Testosterone	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Dutasteride	Dutasteride	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Baclofen	Baclofen	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error